500 Patriot Way,
Lexington, Massachusetts 02421
Hypnion is a biotech company that researches and develops sleep disorder therapies. The company was set up in 2000 by a number of authoritative names in the field of sleep disorder research. It owns the rights to SCORE- 2004™, a method for testing drugs used to treat sleep and waking disorders, which allows quick and accurate measurement of the impact of a particular drug on a broad range of sleep and waking parameters.
Hypnion was acquired by Eli Lilly on March 05, 2007.
Join Mergr to view all 126 acquisitions of life science companies in 2007, including 26 acquisitions by private equity firms, and 100 by strategics.
Out of 60 sectors in the Mergr database, life science ranked 11 in number of deals in 2007. The largest life science acquisition in 2007 was Organon BioSciences N.V. - which was acquired by Schering-Plough for $12.4B.
Join Mergr to view this profile - and discover more life science acquisitions of companies like Hypnion.
No obligation. Cancel anytime.